{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:41:34Z","timestamp":1760910094900,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009414","name":"Veneto Institute of Oncology Institute for Hospitalization and Care Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.cyto.2021.155622","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T20:35:52Z","timestamp":1624048552000},"page":"155622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification"],"prefix":"10.1016","volume":"146","author":[{"given":"Loredana","family":"Urso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micol","family":"Silic-Benussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Boscolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Lorenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5792-4683","authenticated-orcid":false,"given":"Francesca","family":"Lunardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Guarneri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorella","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Rea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PierFranco","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Pasello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2021.155622_b0005","first-page":"402","article-title":"Mesothelioma: Scientific clues for prevention, diagnosis, and therapy","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"10.1016\/j.cyto.2021.155622_b0010","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.cyto.2021.155622_b0015","doi-asserted-by":"crossref","first-page":"P1734","DOI":"10.1016\/j.annonc.2020.09.009","article-title":"A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9\u201315) PROMISE-meso trial","volume":"31","author":"Popat","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cyto.2021.155622_b0020","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural 1 mesothelioma: results from 2 the global, randomised, open-label phase 3 CheckMate 743 trial","volume":"15:E42)","author":"Baas","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.cyto.2021.155622_b0025","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/annonc\/mdy086","article-title":"Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time","volume":"29","author":"Pasello","year":"2018","journal-title":"Ann Oncol."},{"issue":"11","key":"10.1016\/j.cyto.2021.155622_b0030","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00262-011-1103-6","article-title":"Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma","volume":"60","author":"Bograd","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.cyto.2021.155622_b0035","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.lungcan.2019.11.013","article-title":"Detection of TGF-\u03b2 in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma","volume":"139","author":"Stockhammer","year":"2020","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.cyto.2021.155622_b0040","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jtho.2016.06.022","article-title":"Pleural Effusions from Patients with Mesothelioma Induce Recruitment of Monocytes and Their Differentiation into M2 Macrophages","volume":"11","author":"Chene","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"9","key":"10.1016\/j.cyto.2021.155622_b0045","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3389\/fonc.2019.01366","article-title":"The Immune Microenvironment in Mesothelioma: Mechanisms of Resistance to Immunotherapy","volume":"6","author":"Chu","year":"2019","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.cyto.2021.155622_b0050","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fonc.2019.00740","article-title":"Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives","volume":"14","author":"Cavallari","year":"2019","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.cyto.2021.155622_b0055","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming Growth Factor-\u03b2 Signaling in Immunity and Cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2021.155622_b0060","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1186\/s12885-019-6419-1","article-title":"Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients","volume":"19","author":"Kishimoto","year":"2019","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.cyto.2021.155622_b0065","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1158\/1535-7163.MCT-10-0258","article-title":"Cisplatin Treatment Induces a Transient Increase in Tumorigenic Potential Associated with High Interleukin-6 Expression in Head and Neck Squamous Cell Carcinoma","volume":"9","author":"Poth","year":"2010","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.cyto.2021.155622_b0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41416-019-0661-9","article-title":"Metabolic rewiring and redox alterations in malignant pleural mesothelioma","volume":"122","author":"Urso","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cyto.2021.155622_b0075","doi-asserted-by":"crossref","unstructured":"Floris Dammeijer,Cornedine J De Gooijer,Mandy van Gulijk et al. Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response. EBioMedicine 2020 Dec 22;103160.","DOI":"10.1016\/j.ebiom.2020.103160"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621002088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621002088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:00:36Z","timestamp":1760907636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621002088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":15,"alternative-id":["S1043466621002088"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155622","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"155622"}}